VAN ECK ASSOCIATES CORP - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 30 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$37,000
-32.7%
7,849
+1.5%
0.00%
Q4 2020$55,000
-68.0%
7,733
-52.6%
0.00%
Q3 2020$172,000
+21.1%
16,298
+2.1%
0.00%
Q2 2020$142,000
+688.9%
15,958
+232.3%
0.00%
Q1 2020$18,0000.0%4,802
+3.5%
0.00%
Q4 2019$18,000
+5.9%
4,638
+0.8%
0.00%
Q3 2019$17,0004,6020.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 384,709$1,523,0000.74%
Green Alpha Advisors, LLC 50,555$200,0000.14%
Values First Advisors, Inc. 47,534$188,0000.13%
GSA CAPITAL PARTNERS LLP 159,731$633,0000.07%
SHELTON CAPITAL MANAGEMENT 220,000$871,0000.03%
Focused Wealth Management, Inc 41,000$162,0000.03%
ALGERT GLOBAL LLC 15,690$62,0000.02%
SG3 Management, LLC 150,000$594,0000.02%
Susquehanna International Group Ltd. 13,902$55,0000.02%
MEITAV INVESTMENT HOUSE LTD 335,186$1,328,0000.02%
View complete list of PLURISTEM THERAPEUTICS INC shareholders